Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States

2011 ◽  
Vol 58 (3) ◽  
pp. 409-417 ◽  
Author(s):  
David M. Charytan ◽  
Amanda R. Patrick ◽  
Jun Liu ◽  
Soko Setoguchi ◽  
Charles A. Herzog ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

scholarly journals Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001

2004 ◽  
Vol 44 (4) ◽  
pp. 855-858 ◽  
Author(s):  
Andrew Voigt ◽  
Rana Ezzeddine ◽  
William Barrington ◽  
Ogundu Obiaha-Ngwu ◽  
Leonard I. Ganz ◽  
...  
Keyword(s):  
United States ◽  
Cardiac Arrest ◽  
The United States ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

scholarly journals 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States

2011 ◽  
Vol 58 (10) ◽  
pp. 1001-1006 ◽  
Author(s):  
Arnold J. Greenspon ◽  
Jasmine D. Patel ◽  
Edmund Lau ◽  
Jorge A. Ochoa ◽  
Daniel R. Frisch ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

Parameters Influencing Distal Tip Loading of Pacemaker and Defibrillator Leads

2013 ◽  
Author(s):  
Donna Walsh ◽  
Beth Stephen ◽  
Nandini Duraiswamy ◽  
Oleg Vesnovsky ◽  
L. D. Timmie Topoleski
Keyword(s):  
Pulse Generator ◽  
Superior Vena ◽  
Vena Cava ◽  
The United States ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Wall ◽  
Active Fixation ◽  
Passive Fixation ◽  
Cardioverter Defibrillators ◽  
Heart Implantation

More than 235,000 pacemakers and 130,000 implantable cardioverter defibrillators (ICD) were implanted in the United States in 2009 [1] for the treatment of various cardiac arrhythmias. Traditional pacemakers and ICDs deliver therapy to the patient through a transvenous lead that extends from a subcutaneously-implanted pulse generator, through the subclavian or cephalic vein, the superior vena cava (SVC), and into the heart. Attachment of the distal tip of the lead into the cardiac muscle is accomplished through either an active fixation mechanism where a metal helix is screwed into the cardiac wall at the time of implantation, or a passive fixation mechanism where silicone tines are ensnared by the fibrous trabeculae within the heart. Implantation of both active and passive leads is aided by the insertion of a stylet, or thin wire, into the lead to provide additional stiffness and steerability as the device is pushed through the vasculature and to the implant site.

Sign in / Sign up

Export Citation Format

Share Document